Clinical Trials Browser

Phase 2 × Advanced Solid Tumors × toripalimab × Clear all

NCT04169672 2023-03-02

Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors

Phase 2 Completed

Other solid neoplasm

Advanced Solid Tumors